Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CES2 | O00748 | 2/20 | 0.42 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | NAAA | Q02083 | 1/20 | 0.39 |
| ▸ | DGKA | P23743 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27585185 | 0.93 | CES2 (0.50) | TSHRCYP3A4CES2PLA2G4BMAPT | |
| SCHEMBL25832655 | 0.93 | TDP1 (0.45) | TSHRCYP3A4ALDH1A1CES2PLA2G4B | |
| SCHEMBL16968094 | 0.91 | TSHR (0.39) | TSHRCYP3A4ALDH1A1CES2PLA2G4B | |
| SCHEMBL12299382 | 0.91 | TDP1 (0.43) | TSHRCYP3A4ALDH1A1CES2PLA2G4B | |
| SCHEMBL13883578 | 0.89 | KMT2A (0.39) | TSHRCYP3A4ALDH1A1CES2PLA2G4B | |
| Hydrochloric Acid SCHEMBL28339331 | 0.89 | TSHR (0.48) | TSHRCYP3A4ALDH1A1CES2PLA2G4B | |
| SCHEMBL12299381 | 0.86 | TDP1 (0.43) | TSHRALDH1A1CES2PLA2G4BMAPT | |
| SCHEMBL27768270 | 0.86 | MAPT (0.48) | TSHRCYP3A4ALDH1A1CES2MAPT | |
| SCHEMBL13806049 | 0.85 | PLA2G4B (0.41) | TSHRCYP3A4ALDH1A1CES2PLA2G4B | |
| SCHEMBL19293637 | 0.84 | TSHR (0.43) | TSHRALDH1A1CES2MAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101631832-A | Photocurable compositions for preparing ABS-like articles | HUNTSMAN ADV MAT SWITZERLAND | 2010-01-20 | — | — | CN | claimed |
| US-20230192647-A1 | COMPOUNDS FOR INHIBITION OF FIBROBLAST ACTIVATION PROTEIN | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V. V. I. (CZ) | 2023-06-22 | — | — | US | disclosed |
| US-9670232-B2 | Molecular precursor compounds for zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2017-06-06 | — | — | US | disclosed |
| US-9455142-B2 | Molecular precursor compounds for ABIGZO zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-09-27 | — | — | US | disclosed |
| US-9404002-B2 | Molecular precursor compounds for indium gallium zinc oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-08-02 | — | — | US | disclosed |
| US-9310358-B2 | Sugar chain array | SUMITOMO BAKELITE CO., LTD. (JP) | 2016-04-12 | — | — | US | disclosed |
| US-20150218400-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR INDIUM GALLIUM ZINC OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150221772-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150221506-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIGZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150218190-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| CN-101035833-A | Cyclohexene oxide compound with cyclohexyl or long-chain alkyl and application thereof | TOAGOSEI CO LTD (JP) | 2007-09-12 | — | — | CN | disclosed |
| CN-1989145-A | Novel fluorinated alkyl fluorophosphoric acid onium salts and transition metal complex salts | SAN APRO LTD (JP) | 2007-06-27 | — | — | CN | disclosed |
| CN-1311037-C | Resin composition and protective film | JSR CORP (JP) | 2007-04-18 | — | — | CN | disclosed |
| CN-1283709-C | Particle, composition and protective film | JSR CORP (JP) | 2006-11-08 | — | — | CN | disclosed |
| CN-1246402-C | Resin composition and protective film | JSR CORP (JP) | 2006-03-22 | — | — | CN | disclosed |
| CN-1705691-A | Curable composition and rapid prototyping process using same | DSM IP ASSETS BV (NL) | 2005-12-07 | — | — | CN | disclosed |
| CN-1683461-A | Resin composition and protective film | JSR CORP (JP) | 2005-10-19 | — | — | CN | disclosed |
| CN-1458209-A | Resin composition and protective film | JSR CORP (JP) | 2003-11-26 | — | — | CN | disclosed |
| CN-1427043-A | Particle, composition and protective film | JSR CORP (JP) | 2003-07-02 | — | — | CN | disclosed |
| CN-1354763-A | Resin composition for photofabrication of three dimensional objects | DSM NV (NL) | 2002-06-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150218400-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR INDIUM GALLIUM ZINC OXIDE MATERIALS | IKZF3, ZFR, IGSF11 | TSHR 2105/4885CYP3A4 946/4885ALDH1A1 1830/4885 |
| US-20150221506-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIGZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | AOC3, ZRANB2, AOC2 | TSHR 4083/4885CYP3A4 308/4885ALDH1A1 990/4885 |
| US-20150221772-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | IKZF3, ZRANB2, ZFR | TSHR 3832/4885CYP3A4 470/4885ALDH1A1 1090/4885 |
| US-20230192647-A1 | COMPOUNDS FOR INHIBITION OF FIBROBLAST ACTIVATION PROTEIN | FAP, FIBP, APC | TSHR 4445/4885CYP3A4 4079/4885ALDH1A1 1043/4885 |
| US-20150218190-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ZINC-GROUP 13 MIXED OXIDE MATERIALS | ZFR, ZRANB2, IKZF3 | TSHR 3366/4885CYP3A4 128/4885ALDH1A1 3177/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.